{
  "id": 9076156,
  "title": "Stopping Ozempic may raise heart attack and stroke risk",
  "url": "https://urgent.news/2026/09/21/stopping-ozempic-may-raise-heart-attack-and-stroke-risk",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-21T13:35:30.000Z",
  "source": {
    "name": "ScienceDaily",
    "slug": "sciencedaily",
    "url": "https://www.sciencedaily.com/releases/2026/09/260920222414.htm"
  },
  "original_language": "en",
  "account": null,
  "summary": "A large study suggests the cardiovascular benefits of GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound can disappear surprisingly quickly when treatment stops. After two years off the medications, patients had a 22% higher risk of heart attack, stroke, and death compared with those who stayed on them.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "ScienceDaily Health",
        "title": "Stopping Ozempic may raise heart attack and stroke risk",
        "url": "https://urgent.news/2026/09/21/stopping-ozempic-may-raise-heart-attack-and-stroke-risk-9078448",
        "published": "2026-09-21T13:35:30.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}